Osteoporotic fractures - denosumab (TA204)
Fast, easy summary view of NICE guidance on 'osteoporosis'
Specific, concise statements that act as markers of high-quality, cost-effective patient care
NICE recommends denosumab as a possible treatment for preventing bone fractures in some postmenopausal women with osteoporosis (see below).
Who can have denosumab?
If you have not had a bone fracture caused by osteoporosis, you should be able to have denosumab if:
- your doctor thinks you are at risk of having a fracture (see below) and
- you can’t take alendronate and either risedronate or etidronate.
If you have already had a fracture, you should be able to have denosumab if you can’t take alendronate and either risedronate or etidronate.
You can ask your doctor to explain if denosumab is appropriate for you.
Who is at risk?
To see if you are at risk of fracture, your doctor takes into account your age, your bone density, whether your parents had hip fractures, whether you have rheumatoid arthritis and how much alcohol you drink a day. You might need to have a bone scan (known as DXA) to measure your bone density.
Why has NICE said this?
NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended denosumab for certain postmenopausal women who can’t take alendronate and either risedronate or etidronate because it works as well as and costs about the same as other treatments available on the NHS.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: osteoporosis
This page was last updated: 23 August 2013
- Web format
- Quick reference guide (PDF)
- Full Guidance (PDF)
- TA204 Denosumab i atal esgyrn rhag torri mewn merched ag osteoporosis ar ôl diwedd y misglwyf: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.